Yes I agree DNDN progress is paving the way for a more rapid SP growth for Prima (than DNDN had). The market has been given a sense of confidence in this immunology technology. Reducing the risk somewhat. The current SPP is a temporary but necessary hold up in SP growth where the funds are the next step in trying to proove Cvac to the US FDA.
I wouldn't wait too long as many are waiting for the SPP to hurry up and end, especially the huge volume that purchased in the plus 25c level. Positive news should follow which will further accelerate the SP growth as 100mil+ Nasdec funds only just start to enter the stock. The SP is a bargain at any price below price the price before the announcement of the SPP (duor and have fun doing it searching for these dates). All the best
Yes I agree DNDN progress is paving the way for a more rapid SP...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.015(5.36%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.0¢ | $833.4K | 2.824M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 388130 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 39940 | 3 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |